What is tatavax?

Tatavax is a therapeutic vaccine developed by the biotechnology company TATATU, aimed at treating various types of cancer. It works by stimulating the immune system to recognize and attack cancer cells. The vaccine is designed to be personalized, potentially enhancing its effectiveness by tailoring treatment to individual patients. Ongoing clinical trials are assessing its safety and efficacy in cancer treatment.